Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation.
published in: European Journal of Endocrinology
date of publication: 2018-03-02
main subject: homozygosity
Cites articles
There is nothing here
Article - wd:Q52676440